Plasma amyloid β levels are driven by genetic variants near APOE, BACE1, APP, PSEN2: A genome-wide association study in over 12,000 non-demented participants

Alzheimer's Disease Neuroimaging Initiative

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)1663-1674
Number of pages12
JournalAlzheimer's and Dementia
Volume17
Issue number10
DOIs
StatePublished - Oct 2021

Keywords

  • Alzheimer's disease
  • APOE
  • APP
  • BACE1
  • endophenotype
  • genetic epidemiology
  • genome‑wide association study
  • plasma amyloid beta levels
  • plasma biomarkers
  • preclinical biomarkers
  • PSEN2

ASJC Scopus subject areas

  • Epidemiology
  • Health Policy
  • Developmental Neuroscience
  • Clinical Neurology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience

Fingerprint

Dive into the research topics of 'Plasma amyloid β levels are driven by genetic variants near APOE, BACE1, APP, PSEN2: A genome-wide association study in over 12,000 non-demented participants'. Together they form a unique fingerprint.

Cite this